Compared plasma and brain pharmacokinetics of clomipramine and its metabolite demethylclomipramine in two strains of mice (NMRI and CD1).
The fate of clomipramine (CMI) and its main demethylated metabolite demethylclomipramine (DCMI) was studied in two strains of Swiss mice (NMRI and CD1) after intraperitoneal injection. A study of its distribution among various tissues showed that fixation was most marked in lungs, perirenal fat and kidneys, and only moderate in the brain. The pharmacokinetic parameters of both molecules were determined in brain tissue and plasma. Absorption was rapid (tmax CMI = 14 min), metabolism prompt (tmax DCMI = 17 or 18 min according to the breed) and elimination rapid from both plasma and brain tissue. The first two stages were similar in the two strains, but elimination of CMI from both plasma and brain was faster in the NMRI mice (plasma t1/2 = 53 min against 165 min in the CD1 mice). Both values were well below that reported for man (mean plasma t1/2 = 24 h). The data presented can serve as a basis for designing true chronic administration protocol in animals.
Marty
H
H
Laboratoire de Pharmacologie Médicale et INSERM U195, Faculté de Médecine, Clermont-Ferrand, France.
Varoquaux
O
O
Fialip
J
J
Cordonnier
P
P
Duroux
E
E
Bulach
C
C
Eschalier
A
A
Advenier
C
C
Pays
M
M
Bastide
P
P
D000818:Animals; D002997:Clomipramine / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics*; D006207:Half-Life; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D013045:Species Specificity; D014018:Tissue Distribution
C012273:desmethylclomipramine; D002997:Clomipramine